Referential Price System met with strong opposition from public opinion

Published: 2001-07-20 06:59:00

Updated: 2001-07-20 06:59:00

As referential price system started in August can increase medical co-payment of patients and cut off withdrawal of low-priced medicine with no efficacy, it raises objectionable voice against its enforcement.

Especially, it can expand non-allowance area and cause troubles between patient and...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK